SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMULOGIC
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rudy Saucillo who wrote (84)1/8/1997 12:04:00 AM
From: Jeffers Hughes   of 305
 
IMUL have had hard time recently, primarily by the leaving of CEO and the delay of one of its anti-allergy drugs. As a result, most people left this stock. However, I am confident that they will be back soon because 1). the stock is very cheap; 2). IMUL will report its pahse III results of Ragweed in the first week of Feb; 3). IMUL may get its partnership following the positive data of ragweed. It is predicted that the stock will be tripled by the end of years. Just be patient.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News